Journal of Virology & Antiviral ResearchISSN: 2324-8955

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Molecular Assays for the Detection of COVID-19 and Future Prospects

COVID-19 disease is the current challenging global public health concern infectious human pandemic disease, caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2). In December 2019, this COVID-19 disease outbreak form Wuhan city, China and easily spread to several countries around the world. The causative agent of the COVID19 disease, SARS-CoV-2 coronavirus can transmit from an infected person having a respiratory tract symptom to a noninfected person during the incubation period of 2 days to 14 days through coughing, exhaling, sneezing with small droplets from nose or mouth. Humans with pre-existing health problems and also aged people are more vulnerable to acquire the coronavirus COVID-19 disease. The recommended measures to reduce the transmission of this deadly human coronavirus are interrupting human-human contact or apply social distance, taking face mask, stay home and isolate patients at early stages or self-quarantine. Early diagnosis of SARS-CoV-2 coronavirus is the key for quick management of COVID-19 cases and control of the spread of the coronavirus based on the appropriate sample collection. Nowadays, the rapid, accurate and promising molecular laboratory diagnosis assay (such as RT-PCR, microarray, LAMP, point-of care, CRISPR) for detections of SARS-CoV-2 RNA of pathogenic coronaviruses would be valuable to controlling the sources of infection, prevent subsequent secondary spread, saving people’s lives and help patients to prevent the illness evolution.

Special Features

Full Text


Track Your Manuscript

Media Partners